

Digital Asset
Treasury Conference
Digital Asset Treasury Conference
Hosted by Virtual Investor Conferences
January 27th, 2026
Virtual Conference
The Digital Asset Treasury Conference brings together public companies and a global audience of individual and institutional investors for a full day of live, online presentations.
All public companies—whether listed on NYSE, Nasdaq, TSX, CSE, ASX, or the OTC Markets—are welcome and encouraged to participate. The goal is to provide an efficient, accessible venue for issuers to share their story with thousands of investors worldwide.
Virtual Investor Conferences enables companies to present remotely, reach retail and institutional investors at scale, participate in live Q&A, and extend visibility through on-demand replays and analytics.
The January 27th, 2026 virtual investor conference will feature executive presentations from a broad range of digital asset and treasury companies, from emerging innovators to established public issuers.
B2i Digital, Inc. is the Official Marketing Partner of the Digital Asset Treasury Conference Content about any specific company was provided and approved by that company or available in the public domain. B2i Digital, Inc. has not independently verified the accuracy of the information contained herein. The content contained herein is informational only, and no content contained herein shall be considered an offer to solicit the sale of any security or make a recommendation to purchase a security. B2i Digital is not a broker-dealer or investment adviser. Virtual Investor Conferences is an OTC Markets Group Inc. property.

Virtual Investor Conferences (VIC) provides an interactive forum for publicly traded companies to present directly to investors. Offering real-time engagement solutions, VIC helps companies connect with a global audience of retail and institutional investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
![]()
OTC Markets Group Inc. (OTCQX: OTCM) operates a regulated stock market for the trading of over 12,000 U.S. and global securities. They organize these securities into four markets based on the quality and timeliness of the disclosure and the information which the company provides to investors: OTCQX® Best Market, OTCQB® Venture Market, the OTCIDTM Basic Market, and Pink LimitedTM Market.
The OTC Link® Alternative Trading Systems (ATSs) provide the critical market infrastructure broker-dealers rely on to facilitate trading. This innovative model offers companies more efficient access to the U.S. financial markets.
OTC Link ATS, OTC Link ECN, and OTC Link NQB are each an SEC-regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC.

To view the full events calendar, please follow the button below.
Genvor Inc. (OTCQB: GNVR)
Genvor, Inc. (OTC: GNVR) is a biotechnology company pioneering peptide-based solutions for crop protection and plant health. With a focus on sustainable agriculture, Genvor develops and commercializes biological actives that enhance crop performance, reduce chemical inputs, and support regenerative farming systems. Through its partnerships and technology platforms, Genvor is advancing a new era of natural, science-based crop protection For more information, visit www.genvor.com.

Prostatype Genomics AB (OTCQB: PGABF | Nasdaq First North: PROGEN)
Prostatype® is a genetic test available to patients and treating urologists as a complementary decision-making tool when considering treatment or non-treatment of prostate cancer. The test was developed by a research group at Karolinska Institutet and is provided by Prostatype Genomics AB.

